Catalyst Wire Dossier Catalyst Wire Dossier

Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation

bone marrow-derived mesenchymal stem cells · Royan Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation, covering 2015-10-30 to 2015-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Autologous BM-MSC Transplantation in Combination With Platelet Lysate (PL) for Nonunion Treatment [Phase 2, Phase 3]

See pricing